- Home
- RCEL vs GEVO Comparison
RCEL vs GEVO Comparison
Compare RCEL & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- GEVO
- Stock Information
- Founded
- RCEL N/A
- GEVO 2005
- Country
- RCEL United States
- GEVO United States
- Employees
- RCEL N/A
- GEVO N/A
- Industry
- RCEL Medical/Dental Instruments
- GEVO Major Chemicals
- Sector
- RCEL Health Care
- GEVO Industrials
- Exchange
- RCEL Nasdaq
- GEVO Nasdaq
- Market Cap
- RCEL 240.6M
- GEVO 285.1M
- IPO Year
- RCEL N/A
- GEVO 2011
- Fundamental
- Price
- RCEL $6.97
- GEVO $1.16
- Analyst Decision
- RCEL Strong Buy
- GEVO Buy
- Analyst Count
- RCEL 4
- GEVO 2
- Target Price
- RCEL $17.25
- GEVO $7.58
- AVG Volume (30 Days)
- RCEL 197.1K
- GEVO 2.3M
- Earning Date
- RCEL 05-08-2025
- GEVO 05-13-2025
- Dividend Yield
- RCEL N/A
- GEVO N/A
- EPS Growth
- RCEL N/A
- GEVO N/A
- EPS
- RCEL N/A
- GEVO N/A
- Revenue
- RCEL $71,661,000.00
- GEVO $16,915,000.00
- Revenue This Year
- RCEL $62.33
- GEVO $617.82
- Revenue Next Year
- RCEL $30.59
- GEVO $84.22
- P/E Ratio
- RCEL N/A
- GEVO N/A
- Revenue Growth
- RCEL 41.35
- GEVO N/A
- 52 Week Low
- RCEL $6.90
- GEVO $0.48
- 52 Week High
- RCEL $14.16
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- RCEL 28.06
- GEVO 51.71
- Support Level
- RCEL $9.50
- GEVO $1.00
- Resistance Level
- RCEL $9.85
- GEVO $1.14
- Average True Range (ATR)
- RCEL 0.53
- GEVO 0.07
- MACD
- RCEL -0.20
- GEVO 0.01
- Stochastic Oscillator
- RCEL 10.03
- GEVO 69.57
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.